Cryo-Cell International I... (CCEL)
7.40
0.15 (2.07%)
At close: Jan 14, 2025, 3:56 PM
7.75
4.73%
Pre-market Jan 15, 2025, 07:07 AM EST
undefined% (undefined)
| Bid | 4.98 |
| Market Cap | 59.66M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -1.07 |
| PE Ratio (ttm) | -6.92 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8 |
| Volume | 3,354 |
| Avg. Volume (20D) | 23,559 |
| Open | 7.53 |
| Previous Close | 7.25 |
| Day's Range | 7.29 - 7.53 |
| 52-Week Range | 4.47 - 9.50 |
| Beta | undefined |
About CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Apr 4, 1994
Employees 82
Stock Exchange NASDAQ
Ticker Symbol CCEL
Website https://www.cryo-cell.com
Next Earnings Release
Cryo-Cell International Inc. is scheduled to release its earnings on Feb 26, 2025,
after market closes.
Analysts project revenue of $7.94M, reflecting a 0.80% YoY growth and earnings per share of 0.03, making a -86.96% decrease YoY.
Analysts project revenue of $7.94M, reflecting a 0.80% YoY growth and earnings per share of 0.03, making a -86.96% decrease YoY.
